Literature DB >> 19846944

MG-63 osteoblast-like cells enhance the osteoprotegerin expression of PC-3 prostate cancer cells.

Haralampos Katopodis1, Anastassios Philippou, Roxane Tenta, Charles Doillon, Katerina K Papachroni, Athanasios G Papavassiliou, Michael Koutsilieris.   

Abstract

BACKGROUND: Osteoprotegerin (OPG) expression participates in the pathophysiology of osteoblastic metastasis in prostate cancer.
MATERIALS AND METHODS: We investigated whether the expression of OPG of PC-3 prostate cancer cells grown in 3-D collagen gels is stimulated by co-culture with MG-63 osteoblast-like cells. The expression of Runx2 (Cbfa1) and OPG were assessed by reverse transcription-polymerase chain reaction and Western blot analysis.
RESULTS: OPG and Runx2 were expressed in both PC-3 and MG-63 cells. OPG expression was remarkably enhanced in PC-3 cells grown in co-culture with MG-63 cells in a time-dependent manner. Runx2 expression of PC-3 cells was not altered by their co-culture with MG-63 cells. OPG expression of PC-3 cells was altered neither by insulin-like growth factor I (IGF-1), transforming growth factor beta1 (TGFbeta1), interleukin 6 (IL-6) nor by dexamethasone and zoledronic acid exogenously added to PC-3 cells.
CONCLUSION: The enhancement of the OPG expression in PC-3 cells by MG-63 cells is not mediated by IGF-1, IL-6 and TGFbeta1.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19846944

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  3 in total

1.  Prostatic Acid Phosphatase Alters the RANKL/OPG System and Induces Osteoblastic Prostate Cancer Bone Metastases.

Authors:  Alexander Kirschenbaum; Sudeh Izadmehr; Shen Yao; Kieley L O'Connor-Chapman; Alan Huang; Elias M Gregoriades; Shoshana Yakar; Alice C Levine
Journal:  Endocrinology       Date:  2016-10-26       Impact factor: 4.736

2.  A new method to investigate how mechanical loading of osteocytes controls osteoblasts.

Authors:  Marisol Vazquez; Bronwen A J Evans; Daniela Riccardi; Sam L Evans; Jim R Ralphs; Christopher Mark Dillingham; Deborah J Mason
Journal:  Front Endocrinol (Lausanne)       Date:  2014-12-09       Impact factor: 5.555

3.  Evidence for the Possible Biological Significance of the igf-1 Gene Alternative Splicing in Prostate Cancer.

Authors:  Anastassios Philippou; Athanasios Armakolas; Michael Koutsilieris
Journal:  Front Endocrinol (Lausanne)       Date:  2013-03-20       Impact factor: 5.555

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.